arrow
A

Anna Kiialainen

F. Hoffmann-La Roche Ltd
H指数:25
被引数:5,497

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria
2024-06-258
PRE
Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks

每1、2或4周接受emicizumab预防的血友病A儿童和成人的药代动力学和凝血生物标志物

2024-01-013
OAAI
Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single-arm study (STASEY)

使用因子VIII抑制剂长期emicizumab预防血友病A的安全性和有效性: 3b期,多中心,单臂研究 (STASEY)

2022-11-0128
OAAI
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
2019-06-01283
PREAI
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade

在PD-1阻断治疗的非小细胞肺癌中具有转录和功能差异的PD-1 CD8 T细胞库具有预测潜力

2018-06-11821
OAAI
mTORC1 Inhibition Corrects Neurodevelopmental and Synaptic Alterations in a Human Stem Cell Model of Tuberous Sclerosis
2016-04-0185
OAAI
Functional analysis and transcriptional output of the Gottingen minipig genome
2015-11-1421
OAAI
Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
2015-05-011
PRE